ST2/IL-33 Signaling Promotes Malignant Development of Experimental Squamous Cell Carcinoma by Decreasing NK Cells Cytotoxicity and Modulating the Intratumoral Cell Infiltrate

Oncotarget - United States
doi 10.18632/oncotarget.25768
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

IL-33/ST2 Axis Promotes Glioblastoma Cell Invasion by Accumulating Tenascin-C

Scientific Reports
Multidisciplinary
2019English

The IL-33/ST2 Axes Contributes to Hepatocyte Proliferation and Promotes Development of Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2018English

The IL-33-ST2-MyD88 Axis Promotes Regulatory T Cell Proliferation in the Murine Liver

European Journal of Immunology
AllergyImmunology
2018English

Chronic Alcohol Consumption Inhibits Peripheral NK Cell Development and Maturation by Decreasing the Availability of IL-15

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2016English

High Mobility Group Box 1 Promotes Radioresistance in Esophageal Squamous Cell Carcinoma Cell Lines by Modulating Autophagy

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

LncRNA UCA1 Promotes Cell Proliferation, Invasion and Migration of Laryngeal Squamous Cell Carcinoma Cells by Activating WNT/Β‑catenin Signaling Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

circGSK3β Promotes Metastasis in Esophageal Squamous Cell Carcinoma by Augmenting Β-Catenin Signaling

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

PD‑L1 Promotes Head and Neck Squamous Cell Carcinoma Cell Growth Through mTOR Signaling

Oncology Reports
MedicineCancer ResearchOncology
2019English

IL-33 Receptor ST2 Amplifies the Expansion of NK Cells and Enhances Host Defense During Mouse Cytomegalovirus Infection

Journal of Immunology
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy